StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.23 (-12.08%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Genprex price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Genprex's price to book ratio was 0.1× on Nov 11, 2026, against 85.2× a year earlier. Over the last 5 years it ranged from 0.1× to 88.8×, with a median of 39.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−50.3
2025Dec 31, 202550.4×−11.4
2024Dec 31, 202461.8×+37.3
2023Dec 29, 202324.4×−31.3
2022Dec 30, 202255.7×+25.2
2021Dec 31, 202130.5×−126.3
2020Dec 31, 2020156.8×+125.2
2019Dec 31, 201931.6×−3.2
2018Dec 31, 201834.8×–

More Genprex figures

See a number that looks wrong?